| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |